Role of bone sialoprotein in human bone marrow-derived mesenchymal stem cells differentiating into osteoblasts in vitro
B Xia,J Wang,LD Guo,CL Zhan,YH Xiao,CH Yang
DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.37.002
2007-01-01
Abstract:Aim: Bone sialoprotein (BSP) plays an important role in bone mineralization. Whether to enhance osteogenic differentiation of human bone marrow-derived mesenchymal stem cell (hBMSC) cultured in vitro is a sticking point. Methods: The experiment was performed in Department of Medical Research of Guangzhou General Hospital of Guangzhou Area Military Command of Chinese PLA from October 2005 to December 2006. 1 Materials: Two healthy volunteers in this hospital knew the fact and agreed to participate the study. By Ni-NTA affinity purification method, recombinant human BSP was obtained from zymolytic supernatant of Pichia pastoris GS115/ pPICZaA-hbsp established in this lab. 2 Methods: hBMSCs were obtained from iliac bone marrow of healthy volunteers by adhesive culture method. There were 4 groups in this study: BSP group was added in 0.1 nmol/L BSP; osteogenic supplements group was added in 10 nmol/L dexamethasone, 10 mmol/L β-glycerophosphate, and 50 mg/L ascorbic acid; combined group was added in all chemicals of the above two groups; control group received no treatment factors; Each group was treated for 12 days. 3 Evaluations: Cell morphology was observed the light microscope and electron microscopy; Cell growth curves were tested by cell number counting method, cell cycle was examined with flow cytometry. Expression of stem cell marker STRO-1 was analyzed by immunofluorescence cytochemistry and flow cytometry, alkaline phosphatase (ALP) activity was tested by a specific biochemistry kit, and hydroxyapatite crystals were showed by von Kossa staining. Results: 1 After treatment with BSP, shuttle-like hBMSCs became flat, wide and scattered. 2 Compared with control, cell growth curve of BSP group moved rightward, fluorescence at G 0/G 1 phase increased 12.09% (P < 0.01) and that at S phase decreased 65.92% (P < 0.01); STRO-1-positive cell number decreased 26.54%, (P < 0.01). 3 Compared with control, ALP activity of BSP group increased 50.0%, that of osteogenic supplements group increased 59.5%, that of combined group increased 71.43%, and with the treatment time longer, the activity became more higher. 4 The cells in control group were von Kossa staining-negative, while those in the other groups were all positive. Among the other three groups, the black mineralized hydroxyapatite crystals in combined group were the most and the largest; those in BSP group was the least and the smallest; and those in osteogenic supplements group were placed in the middle. Conclusion: BSP can improve the differentiation and mineralization of hBMSCs, and the effects become stronger when it is applied with classic osteogenic supplements together.